Balstilimab

DB15676InvestigationalProtein Based Therapies

Balstilimab: Overview.

Mechanism: Pharmacologically active on Programmed cell death protein 1
Curator reviewed
Code names: AGEN-2034

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

56Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Balstilimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.